Defective Drug - Baycol
Baycol is one of an extraordinarily popular family of cholesterol-lowering drugs called "statins.". It was brought to the market in 1997 by the German drug manufacturer Bayer AG. In August of 2001 it was pulled from the market due to 31 US deaths involving the drug.
The drug was withdrawn because the FDA had received reports of Baycol patients experiencing severe rhabdomyolysis. Rhabdomyolysis involves injury to the kidney caused by toxic effects on muscle cells. Rhabdomyolysis is a condition that causes muscle-cell breakdown (atrophy) . The main symptoms of Rhabdomyolysis are muscle pain, weakness, tenderness, malaise, fever, dark urine, nausea and vomiting. It is potentially life threatening.
If you or someone you love has been injured by Baycol or if you would like more information on the drug, please email us at April@Littlepagebooth.com
- There are currently no articles